Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Navidea Biopharmaceuticals to Host Fourth Quarter 2019 Earnings Conference Call and Corporate Update

Mar 4, 2020

Navidea Biopharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

Feb 14, 2020

Navidea Biopharmaceuticals Announces $4.2 Million Sale of Ohio Court Judgment and $3.4 Million Equity Raise Representing $7.6 Million in Additional Funding

Feb 14, 2020

Navidea Biopharmaceuticals Obtains Partial Dismissal of Claims in New York

Dec 30, 2019

Navidea Biopharmaceuticals Announces $1.9 Million Private Placement

Dec 6, 2019

Navidea Biopharmaceuticals to Present at the 12th Annual LD Micro Main Event

Dec 5, 2019

Navidea Biopharmaceuticals Wins Summary Judgment in Ohio

Dec 2, 2019

Navidea Biopharmaceuticals to Present at the PCG Spotlight Series Conference

Nov 14, 2019

Navidea Biopharmaceuticals Reports Third Quarter 2019 Financial Results

Nov 7, 2019

Navidea Biopharmaceuticals Announces Preclinical Therapeutic Research Collaboration with IMV Inc. to Explore the Potential Combinatory Effect with Their Platform-Based Immunotherapies

Nov 7, 2019
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...43
    © 2023 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap